Drugs / natural killer cell (NK) therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00354172 | Feb 2006 → Aug 2008 | leukemia, myelodysplastic syndrome | Masonic Cancer Center, University of Minnesota | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | natural killer cell (NK) therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00354172 ↗ |
| Modality | Cell therapy | “haploidentical UCB-enriched NK cell (CD3- depleted) infusion” NCT00354172 ↗ |